McKesson, US58155Q1031

McKesson stock: Mizuho lifts target to USD 1,020 for McKesson stock

Published on 10/23/2026 at 16:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson's USD 0.94 dividend is payable January 4, 2027 per share. McKesson stock costs EUR 896.80 on October 23, 2026 at 4:12 p.m. CEST.

Analyst target and payout

  • Mizuho lifted its McKesson target to USD 1,020.00 from USD 905.00 on October 20, 2026.
  • McKesson declared a USD 0.94 quarterly dividend on October 21, 2026.
  • McKesson stock costs EUR 896.80 at Lang & Schwarz on October 23, 2026 at 4:12 p.m. CEST.
  • Second-quarter fiscal 2027 results are scheduled for November 4, 2026.
Börsen-Editorial-Foto vom Trading-Floor mit Charts symbolisiert Börsennotierung von McKesson Corporation ISIN US58155Q1031 an der NYSE, Illustration mit AI erstellt.

McKesson Corporation (ISIN US58155Q1031) is trading at EUR 896.80 at Lang & Schwarz on October 23, 2026 at 4:12 p.m. CEST. The key investor signal is Mizuho's target revision to USD 1,020.00 from USD 905.00, while the firm kept a neutral rating on October 20, 2026, according to MarketBeat.

Mizuho keeps its neutral view

The revised target is 1.34 percent above McKesson's NYSE price of USD 1,006.57 at 10:30 a.m. EDT on October 23, 2026. Mizuho's USD 115.00 increase followed quarterly earnings of USD 9.93 per share and revenue of USD 105.38 billion for the quarter reported on August 5, 2026, figures carried by MarketBeat.

Stock stays near its yearly high

McKesson's NYSE price stood at USD 1,006.57 at 10:30 a.m. EDT on October 23, 2026, against a 52-week range of USD 723.68 to USD 1,030.27. The lower end of that range is 28.11 percent below the price, while the upper end is 2.30 percent above it. Market capitalization was USD 117.4 billion at the same market-data timestamp, with a price-to-earnings ratio of 26.94.

Dividend and earnings dates

McKesson's board declared a quarterly dividend of USD 0.94 per share on October 21, 2026. The payment is due January 4, 2027, to shareholders of record on December 1, 2026, according to McKesson Corporation. The company is scheduled to release second-quarter fiscal 2027 results after the market close on November 4, 2026, with its conference call set for 4:30 p.m. ET, as stated by McKesson Corporation.

Comparison with peers

McKesson: P/E 26.94, market capitalization USD 117.4 billion. Cencora (NYSE, USD): down 0.80 percent, P/E 24.91, market capitalization USD 64.1 billion. Cardinal Health (NYSE, USD): down 0.69 percent, P/E 35.09, market capitalization USD 58.8 billion.

Price remains the market frame

For investors, the contrast is between a share price near the upper end of its 52-week range and a Mizuho target that sits 1.34 percent above the NYSE price. McKesson's next earnings release on November 4, 2026 will provide the next scheduled test of the fiscal 2027 outlook.

The stock was trading at EUR 896.80 at Lang & Schwarz on October 23, 2026 at 4:12 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of McKesson stock.

McKesson at a glance

  • Company: McKesson Corporation
  • ISIN: US58155Q1031
  • WKN: 893953
  • Ticker: MCK
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 23, 2026, 4:12 p.m. CEST): EUR 896.80
  • Market capitalization: USD 117.4 billion (as of October 23, 2026)
  • 52-week range: USD 723.68-1,030.27 (as of October 23, 2026)
  • Sector / Industry: Healthcare / Medical distribution

Market context: Market report S&P 500.

More news and analyses on McKesson stock

Disclaimer...
en | US58155Q1031 | MCKESSON | boerse | 70400049 | bgmi